Emetogenicity of multiday chemotherapy regimens: Drug and patient factors affecting control of CINV.

@article{Howell2009EmetogenicityOM,
  title={Emetogenicity of multiday chemotherapy regimens: Drug and patient factors affecting control of CINV.},
  author={J. Howell and H. Brown},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2009},
  volume={27 15\_suppl},
  pages={e20683}
}
  • J. Howell, H. Brown
  • Published 2009
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
e20683 Background: Multi-day chemo regimens have particular advantages in increasing tolerability and maintaining dose intensity of combination cytotoxic therapy. However repeated daily insults of therapy can make control of CINV challenging. Increased knowledge of factors affecting poor control of multi-day chemo, under current CINV prevention conditions, would be beneficial. METHODS A dataset of 621 patients treated in a blinded, randomised non-inferiority study (Grunberg SM, Gabrial NY… Expand
1 Citations